When patients decide to move forward with drugs like Ozempic despite the listed warnings, they are often unaware of the rare but serious risk of stomach paralysis
Independent laboratory comparisons between compounded synthetic semaglutide and Novo Nordisks branded Ozempic/Wegovy revealed several quality differences
Findings also show improved persistence with high-potency, obesity-approved GLP-1 products EAGAN, Minn., June 25, 2025 /PRNewswire/ -- Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from pharmacy solutions partner Prime Therapeutics LLC (Prime)
Phase 3 trials with larger populations and longer follow-up periods will be essential to characterise the safety profile more comprehensively
Rybelsus (semaglutide) tablets [prescribing information]
Clear dashboards help you audit your history, set boundaries, and export reports